Sign in

    Alex Stern • Lake Street Capital Markets

    Alex Stern is a Senior Research Analyst at Lake Street Capital Markets specializing in equity research for small- and mid-cap growth companies in sectors such as healthcare, technology, and industrials. He regularly covers companies including Veracyte, Omnicell, and Iradimed, delivering investment recommendations that have consistently ranked among the top quartile of analysts on platforms like TipRanks, with a success rate of over 65% and average annualized returns above 15%. Stern began his research career at Lake Street in 2017 and previously gained experience as an associate analyst at a regional investment firm working in the specialty healthcare segment. He holds a FINRA Series 7 and Series 63 license and has been recognized in industry publications for the accuracy of his coverage and actionable market insights.

    Alex Stern's questions to Red Robin Gourmet Burgers Inc (RRGB) leadership

    Alex Stern's questions to Red Robin Gourmet Burgers Inc (RRGB) leadership • Q3 2024

    Question

    Alex Stern, on for Mark Smith, requested a breakdown of the comparable sales trends for the first few weeks of Q4, specifically traffic and price. He also asked if the company was observing any changes in consumer behavior.

    Answer

    Executive Todd Wilson confirmed that the Q4 guidance is grounded in the first four weeks' results, which saw traffic down approximately 4% and price/mix (PPA) up about 6%. Executive G.J. Hart added that while no major shifts in consumer behavior were seen, the company is optimistic about building momentum through its loyalty program and a more stable post-election consumer environment.

    Ask Fintool Equity Research AI